Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
76.50
0.00 (0.00%)
Aug 13, 2026, 5:24 PM IDT

Novolog (Pharm-Up 1966) Financials Overview

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,8041,8052,0221,6431,5081,255
Revenue Growth
-13.01%-10.70%23.01%8.99%20.13%10.73%
Gross Profit
155.37155.83184.95173.76179.7154.67
Operating Income
47.4245.7872.753.9777.8169.41
Net Income
3.554.1239.54-4247.5142.32
Earnings Per Share
0.010.010.08-0.080.090.08
EPS Growth
-87.39%-89.54%--12.20%-3.53%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
The Digital Division
27.627.3526.3126.2925.9825.82
Logistics Division
1,5581,5631,7901,4001,2821,098
Unallocated Adjustments
-2.65-2.63-1.51-1.82-1.62-9.25
Health Services Division
221.12217.88206.73218.59201.85140.84
Total
1,8041,8052,0221,6431,5081,255

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
163.2121.77247.6232.94172.81238.71
Total Debt
176.2183.2198.47215.18212.77166.81
Net Cash (Debt)
-13-61.4449.1317.76-39.9771.9
Net Cash Growth
--176.64%--223.81%
Net Cash Per Share
-0.03-0.120.100.03-0.080.14

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
170.92-0.73158.52200.01132.6583.39
Capital Expenditures
-17.78-17.72-13.39-36.25-44.97-30.64
Free Cash Flow
153.14-18.45145.12163.7787.6852.75
Free Cash Flow Growth
203.96%--11.38%86.79%66.21%60.48%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
8.61%8.63%9.15%10.57%11.92%12.32%
Operating Margin
2.63%2.54%3.60%3.28%5.16%5.53%
Pretax Margin
0.23%0.38%2.85%-1.76%4.50%4.79%
Profit Margin
0.20%0.23%1.96%-2.56%3.15%3.37%
FCF Margin
8.49%-1.02%7.18%9.96%5.81%4.20%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0390.0390.0490.0290.0660.094
Dividend Per Share Growth
-50.01%-20.02%66.66%-55.24%-30.00%262.10%
Dividend Yield
5.12%3.12%2.78%2.23%2.60%3.54%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
110.26155.9323.39-29.6635.53
Forward PE
-14.0214.0214.0214.0214.02
P/FCF Ratio
2.55-6.374.4316.0728.51
PS Ratio
0.220.360.460.440.931.20